Investors
Building the infrastructure for preventive medicine.
Healthcare is reactive
95% of healthcare spending goes toward treating disease after it occurs. Despite advances in diagnostics and therapeutics, the system waits for patients to get sick before acting.
The data to predict and prevent disease already exists, scattered across lab results, wearables, medical records, and patient-reported outcomes. What is missing is the infrastructure to integrate it into actionable, personalized insights.
Virtual twins for healthcare
BioTwin creates computational models of individual health by integrating multi-modal data streams. These "virtual twins" enable healthcare organizations to predict risk, personalize interventions, and measure outcomes at the individual level.
We enter through clinical pilots with preventive care providers and longevity clinics, organizations that need personalized risk stratification and are willing to pay for better patient outcomes. From there, we expand into pharma (patient selection, RWE), payers (population health), and research (cohort analysis).
Leaders investing in virtual twins for healthcare
The virtual twin approach is gaining traction among the world's leading technology and healthcare companies.
Dassault Systemes
"There will be a before and after the virtual twin of the human body."
The Living Heart Project and Emma Twin initiative are advancing virtual twin technology for cardiac care and personalized medicine.
Nvidia
Healthcare digital twins powered by AI simulation
Investing in GPU-accelerated medical simulations and virtual twin platforms through Clara and Omniverse technologies.
Twin Health
Whole Body Digital Twin for metabolic health
Published peer-reviewed clinical results in prestigious journals, demonstrating significant outcomes in diabetes reversal.
Why this matters: When industry giants invest in virtual twin technology for healthcare, it validates the approach and signals a major market shift toward precision medicine.
Current progress
Metrics and milestones coming soon
We are actively building our clinical evidence base and establishing key partnerships. Contact us to learn more about our current progress.
Investors & partners
Investor and partner announcements coming soon
We are in discussions with leading healthcare investors and strategic partners. Reach out to learn more about investment opportunities.
Roadmap
Product roadmap coming soon
We are finalizing our strategic roadmap and key milestones. Contact us to discuss our vision and growth plans.